Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Truls S Ingebrigtsen

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
European Clinical Respiratory Journal|November 23, 2020
Witnessed sleep apneas together with elevated plasma glucose are predictors of COPD exacerbationsTruls S Ingebrigtsen, Jacob L Marott, Peter Lange
Respirology (Carlton, Vic.)|June 22, 2019
Increased risk of major adverse cardiac events following the onset of acute exacerbations of COPDMette Reilev, Anton Pottegård, Jesper Lykkegaard, et al.
Respiratory Medicine|November 13, 2015
Medically treated exacerbations in COPD by GOLD 1-4: A valid, robust, and seemingly low-biased definitionTruls S Ingebrigtsen, Jacob L Marott, Peter Lange, et al.
Respirology (Carlton, Vic.)|October 10, 2014
Gastro-esophageal reflux disease and exacerbations in chronic obstructive pulmonary diseaseTruls S Ingebrigtsen, Jacob L Marott, Jørgen Vestbo, et al.
Thorax|October 29, 2014
Statin use and exacerbations in individuals with chronic obstructive pulmonary diseaseTruls S Ingebrigtsen, Jacob L Marott, Børge G Nordestgaard, et al.
Thorax|August 26, 2015
Fibrinogen and α1-antitrypsin in COPD exacerbationsTruls S Ingebrigtsen, Jacob L Marott, Line Rode, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 14, 2022
Plasma immunoglobulin E and risk of exacerbation and mortality in chronic obstructive pulmonary disease: A contemporary population-based cohortYunus Çolak, Truls S Ingebrigtsen, Børge G Nordestgaard, et al.
Chest|August 31, 2013
Characteristics of undertreatment in COPD in the general populationTruls S Ingebrigtsen, Jacob L Marott, Jørgen Vestbo, et al.
Journal of General Internal Medicine|September 24, 2014
Low use and adherence to maintenance medication in chronic obstructive pulmonary disease in the general populationTruls S Ingebrigtsen, Jacob L Marott, Børge G Nordestgaard, et al.
Respiratory Medicine|July 31, 2019
Prognosis of COPD depends on severity of exacerbation history: A population-based analysisYunus Çolak, Shoaib Afzal, Jacob L Marott, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
European Clinical Respiratory Journal|November 23, 2020
Witnessed sleep apneas together with elevated plasma glucose are predictors of COPD exacerbationsTruls S Ingebrigtsen, Jacob L Marott, Peter Lange
Respirology (Carlton, Vic.)|June 22, 2019
Increased risk of major adverse cardiac events following the onset of acute exacerbations of COPDMette Reilev, Anton Pottegård, Jesper Lykkegaard, et al.
Respiratory Medicine|November 13, 2015
Medically treated exacerbations in COPD by GOLD 1-4: A valid, robust, and seemingly low-biased definitionTruls S Ingebrigtsen, Jacob L Marott, Peter Lange, et al.
Respirology (Carlton, Vic.)|October 10, 2014
Gastro-esophageal reflux disease and exacerbations in chronic obstructive pulmonary diseaseTruls S Ingebrigtsen, Jacob L Marott, Jørgen Vestbo, et al.
Thorax|October 29, 2014
Statin use and exacerbations in individuals with chronic obstructive pulmonary diseaseTruls S Ingebrigtsen, Jacob L Marott, Børge G Nordestgaard, et al.
Thorax|August 26, 2015
Fibrinogen and α1-antitrypsin in COPD exacerbationsTruls S Ingebrigtsen, Jacob L Marott, Line Rode, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 14, 2022
Plasma immunoglobulin E and risk of exacerbation and mortality in chronic obstructive pulmonary disease: A contemporary population-based cohortYunus Çolak, Truls S Ingebrigtsen, Børge G Nordestgaard, et al.
Chest|August 31, 2013
Characteristics of undertreatment in COPD in the general populationTruls S Ingebrigtsen, Jacob L Marott, Jørgen Vestbo, et al.
Journal of General Internal Medicine|September 24, 2014
Low use and adherence to maintenance medication in chronic obstructive pulmonary disease in the general populationTruls S Ingebrigtsen, Jacob L Marott, Børge G Nordestgaard, et al.
Respiratory Medicine|July 31, 2019
Prognosis of COPD depends on severity of exacerbation history: A population-based analysisYunus Çolak, Shoaib Afzal, Jacob L Marott, et al.
Pageof 2